Bumrungrad International Hospital
| Tailândia | Turquia | Áustria | |
| Terapia com Actínio-225 | de $25,000 / 850,000฿ | de $22,955 / 780,470฿ | de $55,000 / 1,870,000฿ |
| Quimioterapia para cancro da mama | de $3,000 / 102,000฿ | de $1,200 / 40,800฿ | de $15,000 / 510,000฿ |
| Gamma Knife em portuguese é Gamma Knife | de $25,000 / 850,000฿ | de $6,300 / 214,200฿ | de $32,000 / 1,088,000฿ |
| Resseção de glioblastoma | - | de $14,400 / 489,600฿ | - |
| Halcyon | - | de $5,400 / 183,600฿ | - |
A Bookimed não adiciona taxas extras aos preços de tratamento de Glioblastoma. As tarifas vêm das listas oficiais de preços das clínicas. O pagamento é feito diretamente na clínica na chegada ao país.
A Bookimed está comprometida com sua segurança. Trabalha apenas com instituições que mantêm altos padrões internacionais no tratamento de Glioblastoma e têm as licenças necessárias para atender pacientes internacionais em todo o mundo.
A Bookimed oferece assistência gratuita de especialistas. Um coordenador médico pessoal apoia antes, durante e após o tratamento, solucionando problemas. Nunca está sozinho em sua jornada de tratamento de Glioblastoma.
Glioblastoma treatment in Thailand follows the international Stupp Protocol. This includes surgical resection followed by chemotherapy and radiation. Advanced options like Gamma Knife and immunotherapy are available. Facilities like Bumrungrad International Hospital provide multidisciplinary neuro-oncology care supported by JCI and Newsweek recognitions.
Bookimed Expert Insight: Thailand ranks fifth globally in our medical tourism data for complex care. Clinics like Bumrungrad International Hospital serve over 1 million patients annually. Half of these are international visitors from 190 countries. This high volume leads to exceptional diagnostic speed. Brain MRI and oncology consultations are often completed within 48 hours.
Patient Consensus: Patients note it is essential to contact major Bangkok hospitals early. They often look for specialized neuro-oncology networks to find the most experienced Thai surgeons.
Thailand leads neuro-oncology care through JCI-accredited centers in Bangkok. These facilities combine neurosurgery and radiation oncology. Centers like Bumrungrad International Hospital utilize Gamma Knife radiosurgery. They feature specialized Horizon Regional Cancer Centers. These institutions rank among Newsweek's best specialized oncology hospitals in Asia.
Bookimed Expert Insight: Bumrungrad International Hospital stands out due to its massive scale. It serves 1 million patients yearly across 70 departments. While many clinics offer neurosurgery, the integration of 1,300 doctors in one facility allows for rapid multidisciplinary coordination. This structure is vital for complex glioblastoma cases requiring immediate oncology and neurology collaboration.
Patient Consensus: Patients note that Thailand is a reputable option for routine neurosurgery and expatriate care. Some advise carefully verifying neuro-oncologist credentials and survival data specifically for high-grade gliomas before starting treatment.
International glioblastoma patients in Thailand receive support through dedicated international patient centers. Multilingual coordinators handle visa logistics and appointment scheduling for complex neuro-oncology cases. Facilities like Bumrungrad International Hospital serve patients from 190 countries. Many centers provide integrated language assistance for diagnosis and surgical planning.
Bookimed Expert Insight: Thai hospitals like Bumrungrad International serve over 500,000 international patients annually. This high volume means their coordination teams are experts at handling complex medical records. They often sync MRI scans and neurosurgeon consultations within 24 hours. This speed is vital for glioblastoma cases where every day counts for treatment.
Patient Consensus: Patients note that while coordinators handle logistics well, using a translator app helps during technical discussions. Many recommend bringing medical records already translated into English to avoid delays during initial oncology reviews.